PeptidePedia The community reference

STEP trial programme: difference between revisions

Diff·revision 23 → 24·03:47, 28 Aug 2025

Difference between revision 23 and revision 24 of STEP trial programme. 2 lines changed; the page grew by 283 bytes.

Revision 23 — 08:00, 4 Aug 2025
SurpassSunniva (talk)
typo
5,251 bytes ±0
Revision 24 — 03:47, 28 Aug 2025
SurpassSunniva (talk)
name the funder in the sentence, per PP:MOS
5,534 bytes +283
41It does not establish outcomes. Weight is an intermediate endpoint; the cardiovascular outcome question was addressed separately by [[SELECT trial|SELECT]]. Nor does it establish durability beyond the trial durations, or effect in populations not studied.41It does not establish outcomes. Weight is an intermediate endpoint; the cardiovascular outcome question was addressed separately by [[SELECT trial|SELECT]]. Nor does it establish durability beyond the trial durations, or effect in populations not studied.
4242
+43Mean figures conceal a wide distribution. In STEP 1 roughly a third of participants on active treatment lost 20% or more and roughly one in seven lost less than 5%. Reporting only the mean, as most secondary coverage does, describes an individual who may not exist.{{r|rubino2021}}
+44
43== References ==45== References ==
44{{reflist}}46{{reflist}}